Thom R. Loree

Thom R. Loree

Auto-generated profile, based on publicly available information

Thom R. Loree

Erie County Medical Center, Department of Head & Neck/Plastic & Reconstructive Surgery, Buffalo, NY 14215, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
DSDaniel L. Stoler
Daniel L. Stoler
PSPhilip J. Smaldino
Philip J. Smaldino
HDHuferesh K. Darbary
Huferesh K. Darbary
MSMaureen A. Sullivan
Maureen A. Sullivan
SPSaurin R. Popat
Saurin R. Popat
TLTom R. Loree
Tom R. Loree
Human papillomavirus 16 (HPV-16) infection and tobacco use are associated with human oropharyngeal cancers. We conducted a study of the role of HPV and tobacco use in base of the tongue (BOT) cancers. DNA from 34 such cancers was subjected to HPV-16 and HPV-18-specific polymerase chain reaction analysis. Demographic and clinicopathologic data were obtained from each patient's medical record. HPV-16 was detected in 68% of tumors. Tobacco use was the only factor found to be significantly associated with HPV status. Tumors from 100% of patients who had never use d tobacco tested positive for HPV, compared with only 56% of those who had ever used tobacco (Fisher exact test, p = 0.024). All tumors were associated with either tobacco use or HPV infection. These findings are consistent with the hypothesis that either tobacco use or HPV infection is necessary to the etiology of BOT tumors, and they suggest that tongue base carcinoma may be prevented by combining HPV vaccination with tobacco avoidance.

18 July 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
MBMark S. Burke
Mark S. Burke
JLJohn T. Loree
John T. Loree
SPSaurin R. Popat
Saurin R. Popat
DFDaniel Ford
Daniel Ford
JKJae Kim
Jae Kim
TLThom R. Loree
Thom R. Loree

8 October 2025 in Cells
Verified
Journal Article
Open access
PDF file
EHErich Horeth
Erich Horeth
TWTheresa Wrynn
Theresa Wrynn
JOJason M Osinski
Jason M Osinski
AGAlexandra Glathar
Alexandra Glathar
JBJonathan Edward Bard
Jonathan Edward Bard
RRRose-Anne Romano
Rose-Anne Romano
The submandibular glands (SMGs), along with the parotid and sublingual glands, generate the majority of saliva and play critical roles in maintaining oral and systemic health. Despite their physiological importance, long-term therapeutic options for salivary gland dysfunction remain limited, highlighting the need for a deeper molecular understanding of SMG biology, particularly in humans. To address this knowledge gap, we have performed transcriptomic- and epigenomic-based analyses and molecular characterization of the human SMG. Our integrated analysis of multiorgan RNA-sequencing datasets has identified an SMG-enriched gene expression signature comprising 289 protein-coding and 75 long non-coding RNA (lncRNA) genes that include both known regulators of salivary gland function and several novel candidates ripe for future exploration. To complement these transcriptomic studies, we have generated chromatin immunoprecipitation sequencing (ChIP-seq) datasets of key histone modifications on human SMGs. Our epigenomic analyses have allowed us to identify genome-wide enhancers and super-enhancers that are likely to drive genes and regulatory pathways that are important in human SMG biology. Finally, comparative analysis with mouse and human SMG and other tissue datasets reveals evolutionary conserved gene and regulatory networks, underscoring fundamental mechanisms of salivary gland biology. Collectively, this study offers a valuable knowledge-based resource that can facilitate targeted research on salivary gland dysfunction in human patients.